Corrective Phases R...
Corcept Therapeutics Inc. (CORT: NASDAQ)
$4.08 -0.01 | -0.24%
06/01/12 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 2.66M | -35,000 | -40,000 | -547,415 | -547,415 | -547,415 | -45,000 |
| Shares Bought | 2.72M | 20,000 | 10,000 | 488,415 | 488,415 | 488,415 | 0 |
| Shares Sold | 60,000 | 55,000 | 50,000 | 1.04M | 1.04M | 1.04M | 45,000 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 53.30M | 33.84M | 49.09M | 49.07M | 50.73M | 50.73M | 50.73M |
| Shares Bought | 26.92M | 4.68M | 16.54M | 13.60M | 19.81M | 19.81M | 19.81M |
| Shares Sold | 1.42M | 2.39M | 5.33M | 5.33M | 4.29M | 4.29M | 4.29M |
Portfolios with CORT
- Portfolio NameUser Type
- Userwayne120
- Userespwes06 Portfolio 1
- ContributorStocks Under-$10 Moving Hig...
- ContributorTop 10 'Buy'-Rated Stocks U...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- Userrubylu02
- UserBarron's Insider Purchases ...
- Usermicahw29 Portfolio 1
- Userrktjky Portfolio 1
Latest CORT Headlines from TheStreet
- Corcept Has Upside Following Drug Approval 02.21.12 | 12:02 pm
- 7 Stocks Under $10 Moving Higher 02.16.12 | 02:02 pm
- These Drugs Stocks Will Win FDA Approval 02.16.12 | 12:02 pm
- Biotech Stock Mailbag: Corcept Therapeutics, Reader Retorts 02.10.12 | 07:02 am
- Play TheStreet's FDA Drug-Approval Contest 01.23.12 | 08:01 am
- 27 Hot Drugs Facing FDA Approval in 2012 12.19.11 | 10:12 am
- Biotech Calendar: Key Dates for March 03.02.11 | 08:03 am
- Danver Bancorp, Dean Foods: Small-Cap Winners 01.21.11 | 01:01 pm
- Biotech Calendar: Key Dates for December 11.30.10 | 07:11 am
- Novartis Cushing's Drug Passes Late-Stage Test 09.22.10 | 07:09 am
Press Releases for CORT
Partner Headlines for CORT
- Company News for February 22, 2012 - Corporate Summary - Zacks 02.22.12 | 10:02 am
- UPDATE: Stifel Nicolaus Increases Target to $9 on Concept Therepeutics - Benzinga 02.21.12 | 09:02 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- Upcoming PDUFA Dates for Sub-$5 Stocks - Seeking Alpha 07.05.11 | 09:07 am
- 14 Oversold Stocks With Bearish Options - Seeking Alpha 07.01.11 | 08:07 am
- 10 Undervalued Biotech Stocks With Insider Buying - Seeking Alpha 06.23.11 | 06:06 am
- 7 Small-Cap Biotechs With Bullish Insider Buying in 2011 - Seeking Alpha 06.12.11 | 05:06 am
- Low Beta Ideas: 22 High Growth, Low Beta Stocks Being Snapped Up by Mutual Funds - Seeking Alpha 06.09.11 | 09:06 am
- Upgrades, Downgrades and Initiations for Monday - Seeking Alpha 06.06.11 | 09:06 am
- UPDATE 2-Corcept hormone disorder drug meets main trial goal - Reuters 12.22.10 | 11:12 am





